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Introduction 
With a prevalence of 1-2%, hidradenitis suppurativa 
(HS) is a chronic inflammatory disease consisting of 
painful abscesses and draining sinus tracts affecting 
one or both axillae, inguinal folds, inframammary 
regions, and gluteal cleft [1]. 
Despite pharmacologic and surgical therapies for 
this condition, recurrence remains a problem [1]. 
Adjunct therapies such as laser hair reduction have 
been utilized in the management of HS. Laser hair 
reduction reduces the frequency of painful flares by 
decreasing the number of hair follicles, sebaceous 
gland activity, and bacteria load in affected areas [2]. 
This article discusses the evidence supporting laser 
hair reduction for medical management of HS and 
the necessity for insurance coverage in this setting. 
 
Discussion 
Hidradenitis suppurativa creates a scarring and 
persistent inflammation of the terminal hair follicles 
of apocrine gland-bearing areas. Laser hair reduction 
targets the hair bulb decreasing the number of hair 
follicles. Long wavelength 1064nm neodymium-
doped yttrium aluminum garnet (Nd:YAG) laser is a 
preferred device to reach the hair bulb and minimize 
unintentional damage to the epidermal basal layer, 
especially in individuals with darker skin. The Nd:YAG 
laser alone can be beneficial for recurrent lesions in 
Hurley stage I and II patients. For patients with more 
advanced disease (Hurley stage II/III), CO2 laser 
vaporization and excision of sinus tracts is a more 
viable option for treatment success [2]. In one study, 
the ND:YAG laser was combined with CO2 deroofing 
in four patients with refractory HS. All patients had 
complete clearance of lesions up to three years [1]. 
Laser hair reduction can be performed safely with 
few side effects, especially in trained hands. The most 
common side effects include hyperpigmentation, 
hypopigmentation, or lack of efficacy. Laser 
treatments are performed in an office-setting with 
no general anesthesia and hospitalization is not 
required. Patients having more invasive therapy such 
as CO2 laser vaporization and excision are able to 
resume low exertional work within 4-5 days 
depending on disease severity [1]. 
Using the HS Lesion, Area and Severity Index Scale in 
evaluating outcomes, a randomized trial of twenty-
two patients with Hurley II and III lesions treated with 
Nd:YAG laser showed a 65% decrease in disease 
severity in the inguinal and axillary region following 
three treatments performed a month apart [3]. Other 
hair reduction lasers such as the 800nm diode laser, 
intense pulsed light therapy, and non-Q switched 
Abstract 
Hidradenitis suppurativa is a chronic, painful disease 
that significantly reduces quality of life. Laser hair 
reduction is one modality that can be used in 
combination with other treatments to ameliorate the 
condition. We argue that insurance should provide 
coverage for this necessary service. 
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ruby laser have been used with success in small case 
series for the treatment of HS [2]. 
Laser hair reduction costs vary depending on 
differing locations of the body (Table 1), [4]. This 
does not include related expenses such as 
prescription medications or consumables. Medical 
therapies for patients with severe HS are also 
expensive; every-other-week injections of 
adalimumab cost approximately $16,000 per year [6]. 
Prolonged antibiotic courses as an alternative for HS, 
such as with tetracycline or clindamycin, may lead to 
long-term consequences that can lead to drug-
resistant bacteria and potential for microbiome 
alteration. Insurance coverage of lasers for  
dermatologic uses is not a new concept. Many 
insurers consider pulsed dye laser (i.e. VBeam) 
treatment medically necessary for infantile 
hemangiomas and will cover the charges pending a 
prior authorization [5]. In a healthcare system in 
which insurance companies are covering laser costs 
for vascular malformations, viral infections, 
ophthalmologic care, and various other conditions, 
patients with serious chronic inflammatory diseases 
affecting the skin should be provided coverage 
towards laser hair reduction. This is a medically 
necessary procedure for the treatment of HS and it 
should be considered part of the routine medical 
treatment options. 
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Table 1. The average, high and low costs of laser hair reduction 
for different areas of the body according to DocShop [4]. 
Area of Body Low Cost High Cost
Neck $600 $900 
Arms $350 $500 
Groin/ Bikini Area $350 $500 
